Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 4/20 | 0.77 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | F10 | P00742 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6974183 | 0.93 | LSS (0.76) | LSSCNR1NPSR1GAANPC1 | |
| SCHEMBL6977994 | 0.91 | LSS (0.93) | LSSNPSR1NPC1RAB9AALDH1A1 | |
| SCHEMBL6981479 | 0.87 | CNR1 (0.59) | LSSCNR1NPSR1GAANPC1 | |
| SCHEMBL6182258 | 0.87 | LSS (1.00) | LSSCNR1NPC1RAB9AF10 | |
| SCHEMBL8310078 | 0.86 | LSS (0.83) | LSSNPC1RAB9AALDH1A1 | |
| SCHEMBL6981670 | 0.85 | LSS (0.76) | LSSCNR1NPSR1GAANPC1 | |
| SCHEMBL6975619 | 0.83 | LSS (0.62) | LSSCNR1NPSR1RAB9AALDH1A1 | |
| SCHEMBL7650545 | 0.83 | CNR1 (0.64) | LSSCNR1NPSR1GAANPC1 | |
| SCHEMBL6977537 | 0.83 | LSS (0.93) | LSSGAANPC1RAB9AALDH1A1 | |
| SCHEMBL8309729 | 0.81 | LSS (0.89) | LSSCNR1NPC1RAB9AF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925286-B1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ASTRAZENECA AB (SE) | 2003-01-02 | — | — | EP | disclosed |
| US-6093718-A | AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | ZENECA LIMITED (GB) | 2000-07-25 | — | — | US | disclosed |
| EP-0925286-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998006705-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1998-02-19 | — | — | WO | disclosed |